Magnesium, iron, and zinc supplementation for the treatment of attention deficit hyperactivity disorder: A systematic review on the recent literature

International Journal of Preventive Medicine

Volumn 2015-September, Issue , 2015, Pages

  Hariri, Mitra ^a,b   Azadbakht, Leila ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Attention deficient hyperactivity disorder; Iron; Magnesium; Zinc

Indexed keywords

DEXAMPHETAMINE; FERROUS CALCIUM CITRATE; FERROUS SULFATE; IRON; MAGNESIUM; METHYLPHENIDATE; PLACEBO; POLYUNSATURATED FATTY ACID; PYRIDOXINE; UNCLASSIFIED DRUG; ZINC; ZINC GLYCINATE; ZINC SULFATE;

ATTENTION DEFICIT DISORDER; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; HUMAN; MONOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

EID: 84941351157     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: 10.4103/2008-7802.164313     Document Type: Review

References (47)

1. Tarver J, Daley D, Sayal K. Attention-deficit hyperactivity disorder (ADHD): An updated review of the essential facts. Child Care Health Dev 2014;40:762-74.
2. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1998;279:1100-7.
3. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-8.
4. Meysamie A, Fard MD, Mohammadi MR. Prevalence of attention-deficit/ hyperactivity disorder symptoms in preschool-aged Iranian children. Iran J Pediatr 2011;21:467-72.
5. Husarova V, Bittsansky M, Ondrejka I, Dobrota D. Correlations of ADHD symptoms with neurometabolites measured by 1H magnetic resonance spectroscopy. Bratisl Lek Listy 2014;115:635-42.
6. Adeyemo BO, Biederman J, Zafonte R, Kagan E, Spencer TJ, Uchida M, et al. Mild traumatic brain injury and ADHD: A systematic review of the literature and meta-analysis. J Atten Disord 2014;18:576-84.
7. Gao Q, Liu L, Qian Q, Wang Y. Advances in molecular genetic studies of attention deficit hyperactivity disorder in China. Shanghai Arch Psychiatry 2014;26:194-206.
8. Akhondzadeh S, Gerbarg PL, Brown RP. Nutrients for prevention and treatment of mental health disorders. Psychiatr Clin North Am 2013;36:25-36.
9. Puri BK, Martins JG. Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids 2014;90:179-89.
10. McCann D, Barrett A, Cooper A, Crumpler D, Dalen L, Grimshaw K, et al. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: A randomised, double-blinded, placebo-controlled trial. Lancet 2007;370:1560-7.
11. Biederman J. Attention-deficit/hyperactivity disorder: A selective overview. Biol Psychiatry 2005;57:1215-20.
12. Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 2001;165:1475-88.
13. Sonuga-Barke EJ, Coghill D, Wigal T, DeBacker M, Swanson J. Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: Structure and associations with clinical characteristics and symptom control. J Child Adolesc Psychopharmacol 2009;19:683-90.
14. Maghsoudi Z, Azadbakht L. How dietary patterns could have a role in prevention, progression, or management of diabetes mellitus? Review on the current evidence. J Res Med Sci 2012;17:694-709.
15. Bakhtiyari M, Ehrampoush E, Enayati N, Joodi G, Sadr S, Delpisheh A, et al. Anxiety as a consequence of modern dietary pattern in adults in Tehran - Iran. Eat Behav 2013;14:107-12.
16. Golub MS, Takeuchi PT, Keen CL, Hendrickx AG, Gershwin ME. Activity and attention in zinc-deprived adolescent monkeys. Am J Clin Nutr 1996;64:908-15.
17. Toren P, Eldar S, Sela BA, Wolmer L, Weitz R, Inbar D, et al. Zinc deficiency in attention-deficit hyperactivity disorder. Biol Psychiatry 1996;40:1308-10.
18. Bekaroglu M, Aslan Y, Gedik Y, Deger O, Mocan H, Erduran E, et al. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: A research note. J Child Psychol Psychiatry 1996;37:225-7.
19. Cortese S, Angriman M, Lecendreux M, Konofal E. Iron and attention deficit/ hyperactivity disorder: What is the empirical evidence so far? A systematic review of the literature. Expert Rev Neurother 2012;12:1227-40.
20. Curtis LT, Patel K. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): A review. J Altern Complement Med 2008;14:79-85.
21. Burhans MS, Dailey C, Beard Z, Wiesinger J, Murray-Kolb L, Jones BC, et al. Iron deficiency: Differential effects on monoamine transporters. Nutr Neurosci 2005;8:31-8.
22. Torimitsu K, Furukawa Y, Tsukada S. Role of magnesium in nerve tissue. Clin Calcium 2012;22:1197-203.
23. Bussing R, Zima BT, Gary FA, Garvan CW. Use of complementary and alternative medicine for symptoms of attention-deficit hyperactivity disorder. Psychiatr Serv 2002;53:1096-102.
24. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.
25. Sarris J, Byrne GJ. A systematic review of insomnia and complementary medicine. Sleep Med Rev 2011;15:99-106.
26. Pase MP, Grima NA, Sarris J. The effects of dietary and nutrient interventions on arterial stiffness: A systematic review. Am J Clin Nutr 2011;93:446-54.
27. Bilici M, Yildirim F, Kandil S, Bekaroglu M, Yildirmis S, Deger O, et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:181-90.
28. Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry 2004;4:9.
29. Arnold LE, Disilvestro RA, Bozzolo D, Bozzolo H, Crowl L, Fernandez S, et al. Zinc for attention-deficit/hyperactivity disorder: Placebo-controlled double-blind pilot trial alone and combined with amphetamine. J Child Adolesc Psychopharmacol 2011;21:1-19.
30. Zamora J, Velásquez A, Troncoso L, Barra P, Guajardo K, Castillo-Duran C. Zinc in the therapy of the attention-deficit/hyperactivity disorder in children. A preliminar randomized controlled trial. Arch Latinoam Nutr 2011;61:242-6.
31. Konofal E, Lecendreux M, Deron J, Marchand M, Cortese S, Zaïm M, et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 2008;38:20-6.
32. Sever Y, Ashkenazi A, Tyano S, Weizman A. Iron treatment in children with attention deficit hyperactivity disorder. A preliminary report. Neuropsychobiology 1997;35:178-80.
33. Huss M, Völp A, Stauss-Grabo M. Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems - An observational cohort study. Lipids Health Dis 2010;9:105.
34. Mousain-Bosc M, Roche M, Polge A, Pradal-Prat D, Rapin J, Bali JP. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism. Magnes Res 2006;19:53-62.
35. Mousain-Bosc M, Roche M, Rapin J, Bali JP. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J Am Coll Nutr 2004;23:545S-8.
36. Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes Res 1997;10:149-56.
37. Esmaillzadeh A, Azadbakht L. Consumption of hydrogenated versus nonhydrogenated vegetable oils and risk of insulin resistance and the metabolic syndrome among Iranian adult women. Diabetes Care 2008;31:223-6.
38. Hesse GW, Hesse KA, Catalanotto FA. Behavioral characteristics of rats experiencing chronic zinc deficiency. Physiol Behav 1979;22:211-5.
39. Millichap JG, Yee MM. The diet factor in attention-deficit/hyperactivity disorder. Pediatrics 2012;129:330-7.
40. Earley CJ, Ponnuru P, Wang X, Patton SM, Conner JR, Beard JL, et al. Altered iron metabolism in lymphocytes from subjects with restless legs syndrome. Sleep 2008;31:847-52.
41. Allen RP, Barker PB, Wehrl FW, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2015;84:105.
42. Sinn N. Nutritional and dietary influences on attention deficit hyperactivity disorder. Nutr Rev 2008;66:558-68.
43. Azadbakht L, Esmaillzadeh A. Dietary patterns and attention deficit hyperactivity disorder among Iranian children. Nutrition 2012;28:242-9.
44. Bac P, Maurois P, Dupont C, Pages N, Stables JP, Gressens P, et al. Magnesium deficiency-dependent audiogenic seizures (MDDASs) in adult mice: A nutritional model for discriminatory screening of anticonvulsant drugs and original assessment of neuroprotection properties. J Neurosci 1998;18:4363-73.
45. Feillet-Coudray C, Coudray C, Wolf FI, Henrotte JG, Rayssiguier Y, Mazur A. Magnesium metabolism in mice selected for high and low erythrocyte magnesium levels. Metabolism 2004;53:660-5.
46. Schmidt CJ, Taylor VL. Release of [3H] norepinephrine from rat hippocampal slices by N-methyl-D-aspartate: Comparison of the inhibitory effects of Mg2+ and MK-801. Eur J Pharmacol 1988;156:111-20.
47. Nogovitsina OR, Levitina EV. Effect of MAGNE-B6 on the clinical and biochemical manifestations of the syndrome of attention deficit and hyperactivity in children. Eksp Klin Farmakol 2006;69:74-7.